MPLTMapLight Therapeutics Inc. Common Stock
11.21USD-7.74%Mkt Cap: 519.90M $P/E: —3d ago
MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combin…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap519.90M $
Enterprise Value218.09M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-161.15M $
Revenue/Share—
Last Price11.21 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees133
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.37
PEG—
EV/EBITDA-0.90
EV/Revenue—
P/S—
P/B1.27
EPS (TTM)-18.45
EPS (Forward)-3.34
52W Range
9.1007% of range40.43
52W High40.43 USD
52W Low9.100 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-35.16%
ROA-33.61%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-138.14M $
CapEx (TTM)473.00K $
FCF Margin—
FCF Yield-18.31%
Net Debt-302.74M $
Net Debt/EBITDA1.25
Balance Sheet
Debt/Equity0.01
Current Ratio16.52
Quick Ratio15.79
Book Value/Sh8.844 USD
Cash/Share6.570 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)26.69 USD
Upside (mean)+138.1%
Target Range13.00 USD – 45.00 USD
$13.00+138.1% to mean$45.00
# Analysts13
Ownership
Shares Out.43.65M
Float16.68M
Insiders63.22%
Institutions55.72%
Short Interest
Short Ratio2.6d
Short % Float16.28%
Short % Out.7.90%
Shares Short3.58M
Short (prev mo.)2.58M
Technical
SMA 5025.75 (-56.5%)
SMA 20022.11 (-49.3%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)1.17M
Avg Vol (10d)539.50K
Technical Indicators
RSI (14)29.9
MACD-4.3142
MACD Signal-4.8347
MACD Hist.+0.5205
BB Upper14.48 USD
BB Middle12.23 USD
BB Lower9.992 USD
BB Width36.65%
ATR (14)1.905 USD
Vol Ratio (20d)0.30x